Using a chronic hepatitis B Registry to support population-level liver cancer prevention in Sydney, Australia

BACKGROUND: Approximately 1% of Australians have chronic hepatitis B (CHB), which disproportionately affects people born in hepatitis B-endemic countries. Currently, approximately half of the people affected remain undiagnosed and antiviral treatment uptake is suboptimal (~5%). This increases the li...

Descripción completa

Detalles Bibliográficos
Autores principales: Robotin, Monica C, Masgoret, Ximena, Porwal, Mamta, Goldsbury, David, Khoo, Chee, George, Jacob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745153/
https://www.ncbi.nlm.nih.gov/pubmed/29339926
http://dx.doi.org/10.2147/CLEP.S146275

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745153/
https://www.ncbi.nlm.nih.gov/pubmed/29339926
http://dx.doi.org/10.2147/CLEP.S146275

Ejemplares similares